MiNK Therapeutics Statistics
Total Valuation
INKT has a market cap or net worth of $40.03 million. The enterprise value is $38.31 million.
Important Dates
The next estimated earnings date is Thursday, March 20, 2025, before market open.
Earnings Date | Mar 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
INKT has 3.96 million shares outstanding. The number of shares has increased by 6.74% in one year.
Current Share Class | 3.96M |
Shares Outstanding | 3.96M |
Shares Change (YoY) | +6.74% |
Shares Change (QoQ) | +6.44% |
Owned by Insiders (%) | 19.43% |
Owned by Institutions (%) | 2.05% |
Float | 1.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | -2.28 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.89
Current Ratio | 0.89 |
Quick Ratio | 0.86 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -120.36% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 58,907.72% |
Revenue Per Employee | n/a |
Profits Per Employee | -$444,526 |
Employee Count | 31 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.57% in the last 52 weeks. The beta is 0.17, so INKT's price volatility has been lower than the market average.
Beta (5Y) | 0.17 |
52-Week Price Change | +7.57% |
50-Day Moving Average | 8.07 |
200-Day Moving Average | 8.27 |
Relative Strength Index (RSI) | 54.73 |
Average Volume (20 Days) | 69,966 |
Short Selling Information
The latest short interest is 14,945, so 0.38% of the outstanding shares have been sold short.
Short Interest | 14,945 |
Short Previous Month | 150,671 |
Short % of Shares Out | 0.38% |
Short % of Float | 1.47% |
Short Ratio (days to cover) | 0.30 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -14.29M |
Pretax Income | -20.59M |
Net Income | -13.78M |
EBITDA | -14.07M |
EBIT | -14.29M |
Earnings Per Share (EPS) | -$3.78 |
Full Income Statement Balance Sheet
The company has $6.33 million in cash and $4.61 million in debt, giving a net cash position of $1.72 million or $0.43 per share.
Cash & Cash Equivalents | 6.33M |
Total Debt | 4.61M |
Net Cash | 1.72M |
Net Cash Per Share | $0.43 |
Equity (Book Value) | -17.55M |
Book Value Per Share | -4.44 |
Working Capital | -823,773 |
Full Balance Sheet Cash Flow
Operating Cash Flow | -10.86M |
Capital Expenditures | n/a |
Free Cash Flow | -10.86M |
FCF Per Share | -$2.74 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
INKT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.74% |
Shareholder Yield | -6.74% |
Earnings Yield | -34.43% |
FCF Yield | -27.14% |
Analyst Forecast
The average price target for INKT is $6.50, which is -35.64% lower than the current price. The consensus rating is "Strong Buy".
Price Target | $6.50 |
Price Target Difference | -35.64% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on January 28, 2025. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Jan 28, 2025 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |